Investors

Symphogen has raised a total of € 317million to date in equity capital through an international investor syndicate including:


Essex Woodlands Health Ventures
Novo A/S
PKA
Sunstone Capital
Gilde Healthcare Partners
Danica Pension
Takeda Ventures, Inc.
Genentech